Clinical trial
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
NCT02897778
Study timeline
Study start (actual)2016-08-24Date precision: day
Registry last updated2022-04-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Neoplasmsunresolved
Neoplasms, Glandular and Epithelialunresolved
Neoplasms by Histologic Typeunresolved
Bronchial Neoplasmsunresolved
Lung Neoplasmsunresolved
Respiratory Tract Neoplasmsunresolved
Thoracic Neoplasmsunresolved
Digestive System Neoplasmsunresolved
Endocrine Gland Neoplasmsunresolved
Carcinoma, Non-Small-Cell Lungunresolved
Lung Diseasesunresolved
Breast Neoplasmsunresolved
Breast Diseasesunresolved
Renal Neoplasmunresolved
Solid Tumorsunresolved
Interventions
EntinostatDRUG
PlaceboDRUG
Sponsors & collaborators
Syndax Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02897778 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.